Search Results - "Carpentier, Y.A."

Refine Results
  1. 1

    Adverse effects of conjugated alpha-linolenic acids (CLnA) on lipoprotein profile on experimental atherosclerosis in hamsters by Plourde, M., Ledoux, M., Grégoire, S., Portois, L., Fontaine, J. J., Carpentier, Y. A., Angers, P., Chardigny, J. M., Sébédio, J. L.

    Published in Animal (Cambridge, England) (01-07-2007)
    “…Conjugated linoleic acids (CLAs) such as rumenic acid (RA) have the potential to alter blood lipid profiles in animals and in humans. In contrast,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    O23 Impact du déséquilibre d’apport nutritionnel en acides gras polyinsaturés sur la genèse d’une stéatose et de l’apoptose dans le foie. Approche expérimentale by Pachikian, B.D, Neyrinck, A, Cani, P.D, Portois, L, de Backer, F, Sohet, F, Sempoux, C, Bindels, L, Malaisse, W, Carpentier, Y.A, Delzenne, N.M

    Published in Diabetes & metabolism (2008)
    “…Introduction Les acides gras polyinsaturés n-3 et n-6 présentent des effets importants dans la régulation du métabolisme lipidique (modulation de l’expression…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Clinical Nutrition University. The place of nutrition in the prevention of cardiovascular diseases (CVDs) by Carpentier, Y.A, Komsa-Penkova, R.S

    “…Summary CVDs, including coronary heart disease (CHD) and stroke, currently represent the major causes of mortality and morbidity all over the world. In Europe,…”
    Get full text
    Journal Article
  10. 10

    Intravenous lipid emulsions to deliver omega 3 fatty acids by Carpentier, Y.A., Hacquebard, M.

    “…A rapid supply of n-3 polyunsaturated fatty acids (PUFA) may be indicated in some acute conditions because of the ability of n-3 PUFA to decrease inflammatory…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition by Pachikian, B D, Neyrinck, A M, Cani, P D, Portois, L, Deldicque, L, De Backer, F C, Bindels, L B, Sohet, F M, Malaisse, W J, Francaux, M, Carpentier, Y A, Delzenne, N M

    Published in BMC physiology (01-12-2008)
    “…There are only few data relating the metabolic consequences of feeding diets very low in n-3 fatty acids. This experiment carried out in mice aims at studying…”
    Get full text
    Journal Article
  12. 12

    Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin by Baldassarre, S., Scruel, O., Deckelbaum, R.J., Dupont, I.E., Ducobu, J., Carpentier, Y.A.

    Published in International journal of cardiology (10-10-2005)
    “…The presence of increased levels of small dense (sd) LDL (phenotype B) is associated with a substantial increase of cardiovascular disease risk. Since lowering…”
    Get full text
    Journal Article
  13. 13

    Metabolism of defined structured triglyceride particles compared to mixtures of medium and long chain triglycerides intravenously infused in dogs by Simoens, Ch, Deckelbaum, R.J, Carpentier, Y.A

    Published in Clinical nutrition (Edinburgh, Scotland) (01-08-2004)
    “…The present study aimed to determine whether including medium-chain fatty acids (MCFA) in specifically designed structured triglycerides (STG) with a MCFA in…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study by Lins, R L, Matthys, K E, Billiouw, J M, Dratwa, M, Dupont, P, Lameire, N H, Peeters, P C, Stolear, J C, Tielemans, C, Maes, B, Verpooten, G A, Ducobu, J, Carpentier, Y A

    Published in Clinical nephrology (01-10-2004)
    “…Patients with end-stage renal disease commonly present with an atherogenic lipid profile characterized by the accumulation of triglyceride-rich, apoprotein…”
    Get more information
    Journal Article
  19. 19
  20. 20